- Home
- IMRX vs MAGN Comparison
IMRX vs MAGN Comparison
Compare IMRX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- MAGN
- Stock Information
- Founded
- IMRX 2008
- MAGN 1864
- Country
- IMRX United States
- MAGN United States
- Employees
- IMRX N/A
- MAGN N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- MAGN Paper
- Sector
- IMRX Health Care
- MAGN Basic Materials
- Exchange
- IMRX Nasdaq
- MAGN Nasdaq
- Market Cap
- IMRX 73.2M
- MAGN 67.4M
- IPO Year
- IMRX 2021
- MAGN N/A
- Fundamental
- Price
- IMRX $1.78
- MAGN $19.23
- Analyst Decision
- IMRX Buy
- MAGN
- Analyst Count
- IMRX 7
- MAGN 0
- Target Price
- IMRX $12.80
- MAGN N/A
- AVG Volume (30 Days)
- IMRX 801.9K
- MAGN 726.5K
- Earning Date
- IMRX 11-13-2024
- MAGN 01-01-0001
- Dividend Yield
- IMRX N/A
- MAGN N/A
- EPS Growth
- IMRX N/A
- MAGN N/A
- EPS
- IMRX N/A
- MAGN N/A
- Revenue
- IMRX N/A
- MAGN $2,175,000,000.00
- Revenue This Year
- IMRX N/A
- MAGN N/A
- Revenue Next Year
- IMRX N/A
- MAGN N/A
- P/E Ratio
- IMRX N/A
- MAGN $31.62
- Revenue Growth
- IMRX N/A
- MAGN N/A
- 52 Week Low
- IMRX $1.00
- MAGN $15.86
- 52 Week High
- IMRX $8.07
- MAGN $35.23
- Technical
- Relative Strength Index (RSI)
- IMRX 37.40
- MAGN N/A
- Support Level
- IMRX $1.52
- MAGN N/A
- Resistance Level
- IMRX $1.93
- MAGN N/A
- Average True Range (ATR)
- IMRX 0.19
- MAGN 0.00
- MACD
- IMRX -0.05
- MAGN 0.00
- Stochastic Oscillator
- IMRX 21.95
- MAGN 0.00
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.